BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4047223)

  • 1. [Health care with a profit goal].
    Donner J
    Ned Tijdschr Geneeskd; 1985 Aug; 129(34):1641-4. PubMed ID: 4047223
    [No Abstract]   [Full Text] [Related]  

  • 2. [From hours to consultations? Honest competition in home care].
    Borghuis T
    TVZ; 1997 Apr; 107(8):215-8. PubMed ID: 9418580
    [No Abstract]   [Full Text] [Related]  

  • 3. The 411 on health discount cards.
    Millar C
    Todays FDA; 2012; 24(2):22-3. PubMed ID: 22536688
    [No Abstract]   [Full Text] [Related]  

  • 4. Promotion and pricing in competitive markets.
    Cleverley WO
    Hosp Health Serv Adm; 1987 Aug; 32(3):329-41. PubMed ID: 10283403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marketing's last hurrah. The integration of pricing decisions.
    Goldman EF
    Adm Radiol; 1987 Jul; 6(7):69-71. PubMed ID: 10283698
    [No Abstract]   [Full Text] [Related]  

  • 6. Pricing in health care organizations. A key component of the marketing mix.
    Marlowe D
    Clin Lab Manage Rev; 1989; 3(1):11-9. PubMed ID: 10292461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pricing health services for purchasers--a review of methods and experiences.
    Waters HR; Hussey P
    Health Policy; 2004 Nov; 70(2):175-84. PubMed ID: 15364147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Review of current health care systems: principle of costing in determining health care fees].
    Koinuma N
    Kango; 1993 Sep; 45(11):132-9. PubMed ID: 8007528
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical marketing mixture--update.
    DeSalvo RJ
    Med Mark Media; 1978 Sep; 13(9):21-2, 24, 26 passim. PubMed ID: 10238520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rationality in health policy and its limitations].
    OrtĂșn Rubio V
    Rev Enferm; 1990 Nov; 13(147):12-5. PubMed ID: 2277893
    [No Abstract]   [Full Text] [Related]  

  • 11. Chains marketing to private payers.
    Fackelmann K
    Mod Healthc; 1986 Mar; 16(6):34. PubMed ID: 10275658
    [No Abstract]   [Full Text] [Related]  

  • 12. Marketing to public-aid recipients: an examination of pharmacy profitability.
    Tootelian DH; Gaedeke RM; Gordon CL
    J Health Care Mark; 1984; 4(4):17-21. PubMed ID: 10311025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifecare communities in the eighties.
    Rose AM
    Issues Health Care; 1981; 2(1):64-7. PubMed ID: 10253132
    [No Abstract]   [Full Text] [Related]  

  • 14. Mergers, acquisitions, and the dialysis market.
    Sullivan JD
    Nephrol News Issues; 2002 Jul; 16(8):30-1. PubMed ID: 12154552
    [No Abstract]   [Full Text] [Related]  

  • 15. Pricing analysis for health care services and products.
    Parsons RJ; Tonkinson RE
    J Health Care Mark; 1987 Dec; 7(4):71-81. PubMed ID: 10285781
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term care's pricing dilemma.
    Buchanan RW
    Contemp Adm Long Term Care; 1981 Feb; 4(2):19-22. PubMed ID: 10298085
    [No Abstract]   [Full Text] [Related]  

  • 17. Baby makers Inc.
    Miller A; Friday C; King P
    Newsweek; 1992 Jun; 119(26):38-9. PubMed ID: 10119483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference price: a tool for pricing new healthcare services.
    Kosenko R; Hill DJ; Baer R
    J Ambul Care Mark; 1991; 4(2):111-20. PubMed ID: 10110434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Community marketing of contraceptives].
    Urrutia JM
    Profamilia; 1987 Sep; 3(9-10):15-6. PubMed ID: 12315076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State action as a shield and a sword in a medical services antitrust context: Parker v. Brown in constitutional perspective.
    Blumstein JF; Calvani T
    Duke Law J; 1978 May; (2):389-441. PubMed ID: 10239064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.